Kentucky Retirement Systems Has $812,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Kentucky Retirement Systems decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 7.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 3,282 shares of the medical technology company’s stock after selling 268 shares during the period. Kentucky Retirement Systems’ holdings in Teleflex were worth $812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of Teleflex by 1.8% during the first quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after buying an additional 96,711 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in shares of Teleflex by 12.0% during the first quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after buying an additional 581,312 shares in the last quarter. Cooke & Bieler LP lifted its holdings in shares of Teleflex by 23.3% during the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after buying an additional 172,335 shares in the last quarter. TD Asset Management Inc lifted its holdings in shares of Teleflex by 12.0% during the second quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock worth $95,928,000 after buying an additional 48,832 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Teleflex by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company’s stock worth $89,526,000 after buying an additional 26,325 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Performance

Teleflex stock opened at $193.07 on Wednesday. Teleflex Incorporated has a 12-month low of $189.93 and a 12-month high of $257.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The business’s 50-day moving average price is $229.33 and its two-hundred day moving average price is $223.34. The stock has a market cap of $8.97 billion, a PE ratio of 38.38, a P/E/G ratio of 1.97 and a beta of 1.18.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter in the previous year, the business posted $3.64 earnings per share. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. As a group, analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date is Friday, November 15th. Teleflex’s payout ratio is 27.04%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on TFX. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Wednesday. Truist Financial restated a “hold” rating and issued a $227.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Stephens raised their price target on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Finally, Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and an average target price of $259.25.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.